2025
ContrasTED: Enhanced CATH Classification in The Encyclopedia of Domains via Contrastive Learning
D Miller, N Bordin, C Orengo
Under review
GOBeacon: An Ensemble Model for Protein Function Prediction Enhanced by Contrastive Learning
W Lin, D Miller, Z Gu, C Orengo
Under review
Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes
A Henry, X Mo, C Finan, MD Chaffin, D Speed, H Issa, S Denaxas, D Miller, et al.
Nature Genetics, 57, 815–828
2024
Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy
SL Zheng, A Henry, D Cannie, M Lee, D Miller, KA McGurk, I Bond, X Xu, et al.
Nature Genetics, 1-13
RNA editing is a molecular clock in unmodified human cells
AE Ghareeb, J Bayne, AZ Wagen, AM Abdelhafid, D Miller, L Cubitt, et al.
bioRxiv, 2024.11.18.624170
CATH v4.4: major expansion of CATH by experimental and predicted structural data
VP Waman, N Bordin, A Lau, S Kandathil, J Wells, D Miller, S Velankar, et al.
Nucleic Acids Research, gkae1087
2021
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration
YD Tseng, BS Hoppe, K Dedeckova, CG Patel, CE Hill-Kayser, DM Miller, et al.
International Journal of Radiation Oncology* Biology* Physics 109(1), 220-230
Final results of a phase I "RadVax" trial of hypofractionated radiation combined with pembrolizumab in patients with metastatic solid tumors
JN Lukens, R Mick, ACC Huang, N Han, M Farwell, TC Mitchell, D Miller, et al.
Journal of Clinical Oncology 39(15_suppl), 2576-2576
2020
Bridging Radiation Therapy Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for relapsed/refractory aggressive B-cell lymphoma
CM Wright, MJ LaRiviere, JA Baron, C Uche, Y Xiao, WT Arscott, D Miller, et al.
International Journal of Radiation Oncology* Biology* Physics
2019
Induction Radiation Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma
MJ LaRiviere, CM Wright, WT Arscott, D Miller, E Weber, DJ Landsburg, et al.
International Journal of Radiation Oncology* Biology* Physics 105(1), S66
2018
Tandem Induction Radiation and Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
WT Arscott, D Miller, JA Jones, N Winchell, S Schuster, JP Plastaras
International Journal of Radiation Oncology* Biology* Physics 102(3), S122
Bi-Institutional Report on Consolidative Proton Therapy after Initial Chemotherapy for Mediastinal Diffuse Large B-Cell and Primary Mediastinal Large B-Cell Lymphomas
JP Plastaras, A Maity, S Flampouri, D Miller, NP Mendenhall, J Svoboda, et al.
International Journal of Radiation Oncology* Biology* Physics 102(3), e350
2017
Rates of Toxicity and Outcomes After Mediastinal Proton Therapy For Relapsed/Refractory Lymphoma
YD Tseng, BS Hoppe, D Miller, A Maity, RH Nanda, NP Mendenhall, et al.
International Journal of Radiation Oncology* Biology* Physics 99(2), S62-S63